We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

Back to rankings

166 hedge funds and large institutions have $2.74B invested in AVANIR PHARMACEUTICALS, INC CL A in 2014 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 45 increasing their positions, 42 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $54.8M | Put options by funds: $23.9M

57% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 44

42% more capital invested

Capital invested by funds: $1.93B → $2.74B (+$812M)

17% more funds holding

Funds holding: 142 → 166 (+24)

7% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 42

50% less funds holding in top 10

Funds holding in top 10: 6 → 3 (-3)

Holders
166
Holders Change
+24
Holders Change %
+16.9%
% of All Funds
4.43%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.08%
New
69
Increased
45
Reduced
42
Closed
44
Calls
$54.8M
Puts
$23.9M
Net Calls
+$30.8M
Net Calls Change
-$90.8M

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$247M
2
WIC
Water Island Capital
New York
+$74.7M
3
OAM
Oxford Asset Management
United Kingdom
+$56.4M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$53.8M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$47.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$219M
2
JG
Jefferies Group
New York
-$79.9M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$64.5M
4
RCM
RA Capital Management
Massachusetts
-$64.2M
5
Millennium Management
Millennium Management
New York
-$47.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
76
Havens Advisors
New York
$2.46M +$2.04M +145,000 New
HH
77
HWG Holdings
Texas
$2.25M +$1.86M +132,517 New
ACM
78
Atika Capital Management
New York
$2.18M -$89K -6,326 -5%
HighTower Advisors
79
HighTower Advisors
Illinois
$2.15M -$997K -70,878 -36%
AIG
80
American International Group
New York
$2.07M +$246K +17,514 +17%
GP
81
GLG Partners
United Kingdom
$2.07M +$1.72M +122,000 New
KM
82
KS Management
New York
$2.03M +$1.69M +120,000 New
SIS
83
Sandell Investment Services
New York
$1.97M +$1.64M +116,270 New
UBS AM
84
UBS AM
Illinois
$1.96M +$197K +14,000 +14%
State Board of Administration of Florida Retirement System
85
State Board of Administration of Florida Retirement System
Florida
$1.76M – – –
PCM
86
Price Capital Management
Louisiana
$1.76M +$1.46M +103,736 New
DekaBank Deutsche Girozentrale
87
DekaBank Deutsche Girozentrale
Germany
$1.75M +$46.4K +3,300 +3%
VOYA Investment Management
88
VOYA Investment Management
Georgia
$1.63M – – –
PAM
89
Panagora Asset Management
Massachusetts
$1.63M +$223K +15,845 +20%
PVI
90
Pura Vida Investments
New York
$1.48M +$1.23M +87,500 New
GC
91
Guggenheim Capital
Illinois
$1.41M +$1.17M +83,079 New
FSA
92
Franklin Street Advisors
North Carolina
$1.36M -$703K -50,000 -38%
UBS Group
93
UBS Group
Switzerland
$1.28M +$1.06M +75,541 New
KAM
94
Kassirer Asset Management
Ontario, Canada
$1.24M +$1.03M +73,200 New
PNC Financial Services Group
95
PNC Financial Services Group
Pennsylvania
$1.21M +$871K +61,882 +652%
HSBC Holdings
96
HSBC Holdings
United Kingdom
$1.19M +$119K +8,450 +14%
VOAM
97
Vertex One Asset Management
British Columbia, Canada
$1.19M +$985K +70,000 New
MNBTD
98
Moody National Bank Trust Division
Texas
$1.18M +$981K +69,732 New
CGOF
99
Condorcet Global Opportunity Fund
New York
$1.16M +$964K +68,500 New
CC
100
Columbia Capital
California
$1.15M +$951K +67,583 New
2 3
4
5 6

AVNR Hedge Fund Activity: Q4 2014 in Review

166 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q4 2014, worth a combined $2.74B — up 42% from $1.93B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new AVNR positions and 44 closed out — a net gain of 25 holders — while 45 added to existing stakes and 42 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $247M. The largest seller was Fidelity Investments, cutting an estimated $219M.

  • 166 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q4 2014, up from 142 in Q3 2014.
  • Funds reported $2.74B of AVANIR PHARMACEUTICALS, INC CL A stock for Q4 2014, up 42% quarter-over-quarter.
  • 69 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q4 2014 and 44 closed out, a net change of +25 holders.
  • The largest AVANIR PHARMACEUTICALS, INC CL A buyer in Q4 2014 was Baker Bros. Advisors, an estimated $247M added.
  • The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q4 2014 was Fidelity Investments, an estimated $219M sold.

Based on aggregated 13F filings for Q4 2014.